FDA clears HeartBeam’s at-home arrhythmia assessment tool
HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia…
News
Teleflex to sell trio of business lines in deals totalling over $2bn
Pulse Biosciences and MD Anderson to study nPulse for thyroid cancer
Roche gains CE Mark for bacterial vaginosis/candida vaginitis assay
Agentic AI in healthcare holds opportunity for European players to arise
Medline seeks $5.37bn in largest healthcare IPO of 2025
Aquapass’s fluid overload therapy system gains marketing approval in Israel
Lunit seeks FDA clearance for breast cancer risk prediction model
